Arbutus Biopharma Corporation

This early-stage study tested a new oral drug called AB-101 in 128 people. The goal was to check its safety and how the body processes it. First, healthy volunteers received single or multiple doses. Then, people with chronic hepatitis B received multiple doses. The drug works by…

This study tested a new drug called AB-729, given together with standard antiviral pills and short courses of interferon, in 43 adults with chronic hepatitis B. The goal was to see if the combination could safely lower virus markers in the blood and allow some participants to sto…